CQN-CA-BELKIN
25.5.2023 21:47:28 CEST | Business Wire | Press release
The sentence just beneath the bullets should read "The BoostCharge Pro Fast Wireless Charger for Apple Watch + Power Bank 10K is now available for $99.99 USD on Belkin.com, and coming soon to select retailers worldwide." (instead of "The BoostCharge Pro Fast Wireless Charger for Apple Watch + Power Bank 10K is now available for $99.99 USD on Belkin.com.")
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230516006027/en/
Belkin BoostCharge™ Fast Wireless Charger for Apple Watch + Power Bank 10K (Photo: Business Wire)
The updated release reads:
BELKIN INTRODUCES THE ULTIMATE POWER BANK – THE BOOSTCHARGE™ FAST WIRELESS CHARGER FOR APPLE WATCH + POWER BANK 10K
Featuring fast charging for Apple Watch and 20W USB-C PD for charging iPhone anytime, anywhere
Belkin, a leading consumer electronics brand for 40 years, today announces a first-of-its-kind power bank providing fast charge capabilities for newer Apple Watch models1 and iPhone simultaneously, on-the-go. Able to fully charge the Apple Watch Series 8 and Apple Watch Series 7 from 0% to 80% in about 45 minutes, and Apple Watch Ultra 0% to 80% in about an hour,2 the BoostCharge Pro Fast Wireless Charger is the perfect solution for portable power in a pinch.
The powerful new charger was designed in California by Belkin’s award-winning design team and intricately engineered to fit most Apple Watch band sizes and styles. It leverages the latest in technology to charge the Apple Watch Series 8 fourteen times, or iPhone 14 twice3.
Product features:
- Supports fast charging for Apple Watch Series 8 and Apple Watch Series 7 from 0% to 80% in about 45 minutes, and Apple Watch Ultra 0% to 80% in about an hour2
- Built with a 20W USB-C PD port for fast charging the power bank itself as well as an additional device
- Provides up to 36 hours of video playback for iPhone 144 with 10,000mAh cell capacity
- Built with overcharge protection and fully certified by USB-IF and MFi to deliver safe, fast, efficient power
- Supports wireless charging for AirPods Pro (2nd generation)
- Includes 12-inch USB-C cable for charging power bank
- Ships in plastic-free retail packaging
- Connected Equipment Warranty covers up to $2500 for peace of mind
The BoostCharge Pro Fast Wireless Charger for Apple Watch + Power Bank 10K is now available for $99.99 USD on Belkin.com, and coming soon to select retailers worldwide.
Media kit is available for download HERE.
About Belkin
Belkin is an accessories market leader delivering power, protection, productivity, connectivity, audio, security, and home automation solutions for a broad range of consumer electronics and enterprise environments. Designed in Southern California and sold in more than 100 countries around the world, Belkin has been a market leader and innovator for 40 years. Its dedication to people-inspired design and quality informs everything from user testing and prototyping process to regulatory compliance, manufacturing and warranty programs. In 2018 Belkin International merged with Foxconn Interconnect Technology to broaden its global influence while maintaining its steadfast focus on R&D, community, education and sustainability.
____________________________
1 Fast charging is only compatible with Apple Watch Series 7, Apple Watch Series 8, and Apple Watch Ultra. Other models will have regular charge times.
2 Testing conducted by Belkin in October 2022; devices tested with latest watchOS 9.0.1 software. Actual results will vary depending on varying factors, including device age, model and usage environment, for individual users.
3 Data based on internal lab testing. Actual results will vary depending on varying factors for individual users.
4 Maximum additional video playback hours calculated by comparing the cell capacity of this power bank with the maximum video playback hours achievable by the iPhone 14 under normal conditions. Actual results will vary depending on varying factors for individual users.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230516006027/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Askey and Canoga Perkins Announce Strategic Collaboration at MWC Barcelona to Deliver Rapid-Deploy 5G Critical Communications Solutions27.3.2026 12:00:00 CET | Press release
Askeyand Canoga Perkinsannounced at Mobile World Congress Barcelona a Global Partnership to Deliver SyncMetra® Network Connectivity Solution, combining Canoga Perkins’ software-defined, IT-operated private 5G network transport along with Askey’s carrier-grade 5G radio access technology. At MWC Barcelona 2026, Askey Computer Corporation and Canoga Perkins announced a strategic partnership to deploy Canoga Perkins' SyncMetra® Platform across enterprise and service provider markets with Askey. This partnership pairs Askey’s carrier-grade radio access capabilities with Canoga Perkins’ industry-leading time-sensitive networking (TSN) and synchronization technology, enabling customers to simplify deployment of ultra-low-latency, highly reliable network services for 5G, edge compute, industrial automation, and mission-critical enterprise applications. The partnership enables joint go-to-market efforts, integrated product offerings, and expanded access to SyncMetra through Askey’s sales channe
SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results27.3.2026 11:40:00 CET | Press release
Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year increase. Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of outstanding shares, was $0.14 for the three months ended December 31, 2025, representing 133% year-over-year increase. EBITDA1, which is calculated by adding depreciation and amo
NIQ Redefines Packaging Intelligence with Monthly, Harmonized Global Performance Visibility27.3.2026 11:00:00 CET | Press release
NIQ’s new solution brings unprecedented clarity into package types, materials, and true consumption across markets, closing critical industry gaps NielsenIQ (NYSE: NIQ), a global leader in consumer intelligence, today announced the launch of its Packaging Strategic Planner Global (SPG) Solution, the first harmonized global platform to deliver monthly visibility into packaging performance across materials, formats, and pack configurations. As packaging innovation accelerates, many organizations continue to rely on fragmented or annual data to inform packaging decisions. The Packaging SPG Solution closes this gap by providing real-time data delivered monthly across regions, enabling brands and packaging partners to uncover trends, grow revenue, and strengthen relationships with CPG and retail partners. Key Highlights: New monthly global packaging tracking capability Coverage across 200+ categories Visibility into 30+ package types and 20 package materials 10+ markets at launch, expanding
European DataWarehouse Claims Its First “Fintech Provider of the Year” Award and a Sixth “Data Provider of the Year” Title at GlobalCapital’s 2026 European Securitisation Awards27.3.2026 08:47:00 CET | Press release
European DataWarehouse (EDW) is pleased to announce that it has been named both “Data Provider of the Year” and “Fintech Provider of the Year” at the 2026 GlobalCapital European Securitization Awards in London. The award ceremony recognises outstanding achievements in European structured finance, with winners selected by popular vote from across the industry. As defined by GlobalCapital, the programme celebrates “the very best in the market, as chosen by the market.” This latest recognition marks the sixth time that EDW has received the prestigious Data Provider of the Year award, having previously been honoured in 2019, 2022, 2023, 2024 and 2025, reaffirming its long-standing commitment to transparency, data quality and innovation in European securitisation. Prof. José Manuel González-Páramo, Chairman of EDW, later commented: “ Winning this award for the sixth time highlights the continued trust the European securitisation market places in EDW. Transparency, data quality and reliabili
Biocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors27.3.2026 01:00:00 CET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner NEOK Bio, Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) of an investigational new drug (IND) application for NEOK002, an EGFR/MUC1-targeting ADC program for solid tumors. NEOK Bio plans to initiate a Phase 1 clinical study in the second quarter of 2026 and expects to report initial data in 2027. This IND clearance marks an important milestone for NEOK002, an EGFR/MUC1-targeting ADC candidate developed by NEOK Bio and built on a bispecific antibody originally developed by Biocytogen and licensed in 2024. According to NEOK Bio, NEOK002 is being advanced for solid tumors and may offer differentiated efficacy and safety compared with monospecific ADC approaches directed at either target alone. Dr. Yuelei Sh
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom